Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia-Reference-Cited by-同舟云学术

Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia

Published:2024-07 Issue: Volume: Page:
ISSN:0012-3692
Container-title:CHEST
language:en
Short-container-title:CHEST

Author:

Weckler Barbara Christine^ORCID,Pott Hendrik^ORCID,Race Alan^ORCID,Jugkaeo Nattika,Karki Kapil,Ringshandl Stephan^ORCID,Seidemann Christian,Schöndorf Ines^ORCID,Renz Harald^ORCID,Fähndrich Sebastian,Jung Anna Lena^ORCID,Bertrams Wilhelm^ORCID,Makoudjou Adeline,Zöller Daniela^ORCID,Finotto Susetta^ORCID,Schild Stefanie,Seuchter Susanne A.^ORCID,Rohde Gernot^ORCID,Trinkmann Frederik,Greulich Timm^ORCID,Vogelmeier Claus Franz^ORCID,Schmeck Bernd^ORCID

Publisher

Elsevier BV

Reference8 articles.

1. The Top 10 Causes of Death,2020

2. New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare quality;Ewig;Thorax,2009

3. Eosinopenia predicting long-term mortality in hospitalized acute exacerbation of COPD patients with community-acquired pneumonia: a retrospective analysis;Mao;Int J Chron Obstruct Pulmon Dis,2021

4. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia;Cazzaniga;Int J Clin Pract,2021

5. DataSHIELD: taking the analysis to the data, not the data to the analysis;Gaye;Int J Epidemiol,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study;Journal of Clinical Medicine;2024-09-01